As per available reports about 18 Relevant journals, 25 Conferences, 16 Workshops are presently dedicated exclusively to Hormone replacement therapy and about 2,070 articles are being published on Hormone replacement therapy.
Hormone replacement therapy (HRT) is any form of hormone therapy wherein the patient, in the course of medical treatment, receives hormones, either to supplement a lack of naturally occurring hormones, or to substitute other hormones for naturally occurring hormones. It involves the use of one or more of a group of medications designed to artificially boost hormone levels.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance
There are abundant and conclusive data showing the positive effect of hormone replacement therapy (HRT) on menopausal symptoms and reduction of long-term menopausal risks. At present the opportunity for HRT is somewhat limited, and physicians are to a degree to blame in this situation by not vigorously counteracting inaccurate popular perceptions of the dangers and benefits of HRT. Life style may be taken to be a cluster of interrelated behaviour patterns that depend upon social and economic conditions, education, age, and other factors. The importance of some of these factors in terms of illness and longevity is striking. Good health is well correlated with higher income. There is generally recognized close association between lifestyle and health, even if the exact nature, and importance, of various aspects of the relationship is under investigation, including that between life style and menopause.
Hormone replacement therapy (HRT) is given to some women whose estrogen and progesterone levels drop significantly because of the menopause. HRT may be taken in the following forms: Cream/Gel - it is placed either on the skin or in the vagina if the woman has vaginal dryness, Tablets, Skin patch. The aim of HRT is to restore female hormone levels, allowing the body to function normally again. Menopause is the time in a woman's life when her period stops. It is a normal part of aging. In the years before and during menopause, the levels of female hormones can go up and down. This can cause symptoms such as hot flashes and vaginal dryness. HRT is approved for the relief of menopausal symptoms and the prevention or treatment of osteoporosis.
The total U.S. market for HRT for menopause is currently close to $3.5 billion. Pfizer’s Premarin and Prempro dominate the branded pharmaceutical market with approximately $1 billion in U.S. sales in 2012, down from a peak of nearly $2 billion in 2001. The number of treated women in the U.S. will increase from 5.5 million in 2010 to 6.2 million in 2013, then to over 7 million by 2017. The global hormone replacement therapy market is expected to rise to approximately USD 3.6 billion by 2018. Also it is forecast that the CAGR will be 2.5%. The estrogen administration segment is expected to be the largest in this market with a CAGR of 2.8%. The estrogen market shall be followed by growth hormones, thyroid hormones and testosterone hormone administration. The largest market share is taken by estrogen replacement therapy administered to post-menopausal women. It is followed by growth hormone and thyroid hormone replacement therapies in children and the elderly. The major market for hormone replacement therapy is North America and other developed nations spread worldwide owing to the high purchasing power of the patients and growing awareness. However financially weak nations don’t show much prospect in this advanced and highly sophisticated therapy market. The Asia Pacific market shows high growth potential for existing market players and also the new entrants.
List of Best International Conferences
1. 6th Healthcare and Fitness Conference
August 22-24, 2016 Philadelphia, USA
2. Euro Health Care and Fitness Conference
September 01-03, 2015 Valencia, Spain
3. 3rd Endocrinology Conference
November 02-04, 2015 Atlanta, Georgia, USA
4. 2nd Gynecology and Obstetrics Conference
November 16-18, 2015 San Antonio, USA
5. 3rdGynecology and Obstetrics Conference
October 17-19, 2016 Dubai, UAE.
6. Polycystic Ovarian Syndrome Conference
November 12-18, 2015 Seattle, USA
7. 2ndPolycystic Ovarian Syndrome Conference
October 06-08, 2016 Miami, USA
This page will be updated regularly.
This page was last updated on December 1, 2023